Global Blood Therapeutics, Inc. 4/A SEC Filings

Filed On	Filing
06 Jan 2022	Form 4/A: Love Ted W, Director Returned 24,821 shares to the issuer ($84.4K)
24 Sep 2021	Form 4/A: Choi Jung, See Remarks Received 9,020 shares by exercise or conversion · Gave up 3,743 shares to cover exercise price or tax ($102K)
24 Sep 2021	Form 4/A: Farrow Jeffrey S, Chief Financial Officer Received 9,020 shares by exercise or conversion · Gave up 4,354 shares to cover exercise price or tax ($119K)
24 Sep 2021	Form 4/A: Johnson David Lee, Chief Commercial Officer Received 6,770 shares by exercise or conversion · Gave up 2,342 shares to cover exercise price or tax ($64K)
24 Sep 2021	Form 4/A: Love Ted W, Director Received 29,955 shares by exercise or conversion · Gave up 14,853 shares to cover exercise price or tax ($406K)
24 Sep 2021	Form 4/A: Suvari Tricia Borga, Chief Legal Officer Received 9,395 shares by exercise or conversion · Gave up 3,250 shares to cover exercise price or tax ($88.8K)
21 Jun 2021	Form 4/A: Smith-Whitley Kim, See Remarks Granted 42,400 Restricted Stock Units
22 Jun 2017	Form 4/A: Patrick Deval L, Director Holds 0 shares of Common Stock
14 Mar 2016	Form 4/A: Choi Jung, See Remarks Received 749 shares as a grant or award ($12.1K)
14 Mar 2016	Form 4/A: Choi Jung, See Remarks Bought 25,000 shares ($500K)
07 Jan 2016	Form 4/A: Ramos Eleanor, Chief Medical Officer Bought 11,000 shares ($220K) · Bought 1,000 shares ($30.3K)

Comments